Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against BioScrip, Inc. (NASDAQ: BIOS)
02 Octobre 2013 - 10:01PM
Marketwired
On September 30, 2013, a class action lawsuit was filed in the
United States District Court for the Southern District of New York
against BioScrip, Inc. (NASDAQ: BIOS). The complaint alleges
violations of federal securities laws, Sections 10(b) and 20(a) of
the Securities Exchange Act of 1934 and Rule 10b-5, including
allegations of issuing a series of material or false
misrepresentations to the market which had the effect of
artificially inflating the market price during the Class Period,
which is August 8, 2011 through September 20, 2013.
Plaintiff seeks to recover damages on behalf of all BioScrip,
Inc. shareholders who purchased common stock during the Class
Period and are therefore a member of the Class as described above.
You may move the Court no later than Friday, November 29, 2013 to
serve as a lead plaintiff for the entire Class. However, in order
to do so, you must meet certain legal requirements pursuant to the
Private Securities Litigation Reform Act of 1995.
If you wish to discuss this action, obtain further information
and participate in this or any other securities litigation, or
should you have any questions or concerns regarding this notice or
preservation of your rights, please contact:
K. Lynn Nunn FEDERMAN & SHERWOOD 10205 North Pennsylvania
Avenue Oklahoma City, OK 73120 Email to: kln@federmanlaw.com Or,
visit the firm's website at www.federmanlaw.com
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Sept 2024 à Oct 2024
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Oct 2023 à Oct 2024
Real-Time news about BioPlus Acquisition Corporation (NASDAQ): 0 recent articles
Plus d'articles sur Federman & Sherwood